Prevalence of comorbid disease and associated risk factors among homeless people living in temporary shelters during the COVID-19 lockdown in Tshwane, South Africa

dc.contributor.authorPhiri, T.V.
dc.contributor.authorGloeck, Natasha R.
dc.contributor.authorMusekiwa, Alfred
dc.contributor.emailalfred.musekiwa@up.ac.zaen_US
dc.date.accessioned2024-02-01T07:30:23Z
dc.date.available2024-02-01T07:30:23Z
dc.date.issued2023-09
dc.description.abstractBACKGROUND : People experiencing homelessness are among the most socially and medically vulnerable populations. Objectives. To assess the prevalence of comorbid disease and associated risk factors among homeless people admitted to temporary shelters in the City of Tshwane during levels 4 and 5 of the COVID-19 national lockdown in South Africa. METHODS : A descriptive cross-sectional study design was used. The sample was drawn from secondary data on all individuals placed in temporary shelters constructed by Tshwane during levels 4 and 5 of the COVID-19 lockdown (26 March - 31 May 2020). Descriptive statistics were used to summarise data, and a multivariable logistic regression model was applied to determine factors associated with comorbid disease. RESULTS : The overall prevalence of comorbid disease among homeless people in temporary shelters in Tshwane was 28.8% (95% confidence interval (CI) 26.9 - 30.8). There was no significant difference in the prevalence of comorbid disease by illicit substance use (29.9% for users v. 29.5% for non-users; p=0.871). In adjusted analyses, being South African (adjusted odds ratio (aOR) 2.06; 95% CI 1.10 - 3.88; p=0.024), being female (aOR 3.73; 95% CI 1.85 - 7.53; p<0.001), being black (aOR 3.43; 95% CI 1.12 - 10.54; p=0.031) or white (aOR 6.11; 95% CI 1.55 - 24.0; p=0.01), and injecting substances (aOR 1.68; 95% CI 1.19 - 2.37; p=0.003) were significantly associated with having comorbid disease. CONCLUSION : The study found a 28.8% prevalence of comorbid disease among homeless people placed in temporary shelters in Tshwane. In adjusted analysis, being South African, being female, black and white race, and injecting substances were associated with having comorbid disease. Strengthening of public health interventions such as needle and syringe exchange programmes, family planning and access to primary care with health education could improve the healthcare of people experiencing homelessness.en_US
dc.description.departmentFamily Medicineen_US
dc.description.departmentSchool of Health Systems and Public Health (SHSPH)en_US
dc.description.librarianam2024en_US
dc.description.sdgNoneen_US
dc.description.urihttps://journals.co.za/journal/m.samjen_US
dc.identifier.citationPhiri, T.V., Gloeck, N., Musekiwa, A. 2023, 'Prevalence of comorbid disease and associated risk factors among homeless people living in temporary shelters during the COVID-19 lockdown in Tshwane, South Africa', South African Medical Journal, vol. 113, no. 9, pp. 1392-1396. https://DOI.org/10.7196/SAMJ.2023.v113i9.668.en_US
dc.identifier.issn0256-9574 (print)
dc.identifier.issn2078-5135 (online)
dc.identifier.other10.7196/SAMJ.2023.v113i9.668
dc.identifier.urihttp://hdl.handle.net/2263/94213
dc.language.isoenen_US
dc.publisherSouth African Medical Associationen_US
dc.rights© This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.en_US
dc.subjectHomelessnessen_US
dc.subjectRisk factorsen_US
dc.subjectCOVID-19 pandemicen_US
dc.subjectSouth Africa (SA)en_US
dc.subjectCoronavirus disease 2019 (COVID-19)en_US
dc.subjectTemporary sheltersen_US
dc.subjectTshwaneen_US
dc.titlePrevalence of comorbid disease and associated risk factors among homeless people living in temporary shelters during the COVID-19 lockdown in Tshwane, South Africaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Phiri_Prevalence_2023.pdf
Size:
158.84 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: